Pilot Study of APD209 in Cancer Cachexia

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions
Cancer-related Cachexia
Interventions
DRUG

APD209

Oral tablets twice per day for 56 days

Trial Locations (1)

Unknown

Royal Infirmary Edinburgh, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Acacia Pharma Ltd

INDUSTRY